Key PointsQuestion
Are race and ethnicity–based COVID-19 outcome disparities in the United States associated with socioeconomic characteristics?
Findings
In this systematic review and meta-analysis of 4.3 million patients from 68 studies, African American, Hispanic, and Asian American individuals had a higher risk of COVID-19 positivity and ICU admission than White individuals. Socioeconomic disparity and clinical care quality were associated with COVID-19 mortality and incidence in racial and ethnic minority groups.
Meaning
In this study, members of racial and ethnic minority groups had higher rates of COVID-19 positivity and disease severity than White populations; these findings are important for informing public health decisions, particularly for individuals living in socioeconomically deprived communities.
Importance
COVID-19 has disproportionately affected racial and ethnic minority groups, and race and ethnicity have been associated with disease severity. However, the association of socioeconomic determinants with racial disparities in COVID-19 outcomes remains unclear.
Objective
To evaluate the association of race and ethnicity with COVID-19 outcomes and to examine the association between race, ethnicity, COVID-19 outcomes, and socioeconomic determinants.
Data Sources
A systematic search of PubMed, medRxiv, bioRxiv, Embase, and the World Health Organization COVID-19 databases was performed for studies published from January 1, 2020, to January 6, 2021.
Study Selection
Studies that reported data on associations between race and ethnicity and COVID-19 positivity, disease severity, and socioeconomic status were included and screened by 2 independent reviewers. Studies that did not have a satisfactory quality score were excluded. Overall, less than 1% (0.47%) of initially identified studies met selection criteria.
Data Extraction and Synthesis
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Associations were assessed using adjusted and unadjusted risk ratios (RRs) and odds ratios (ORs), combined prevalence, and metaregression. Data were pooled using a random-effects model.
Main Outcomes and Measures
The main measures were RRs, ORs, and combined prevalence values.
Results
A total of 4 318 929 patients from 68 studies were included in this meta-analysis. Overall, 370 933 patients (8.6%) were African American, 9082 (0.2%) were American Indian or Alaska Native, 101 793 (2.4%) were Asian American, 851 392 identified as Hispanic/Latino (19.7%), 7417 (0.2%) were Pacific Islander, 1 037 996 (24.0%) were White, and 269 040 (6.2%) identified as multiracial and another race or ethnicity. In age- and sex-adjusted analyses, African American individuals (RR, 3.54; 95% CI, 1.38-9.07; P = .008) and Hispanic individuals (RR, 4.68; 95% CI, 1.28-17.20; P = .02) were the most likely to test positive for COVID-19. Asian American individuals had the highest risk of intensive care unit admission (RR, 1.93; 95% CI, 1.60-2.34, P < .001). The area deprivation index was associated with mortality rates in Asian American and Hispanic individuals (P < .001). Decreased access to clinical care was positively correlated with COVID-19 positivity in Hispanic individuals (P < .001) and African American individuals (P < .001).
Conclusions and Relevance
In this study, members of racial and ethnic minority groups had higher risks of COVID-19 positivity and disease severity. Furthermore, socioeconomic determinants were strongly associated with COVID-19 outcomes in racial and ethnic minority populations.
As of August 19, 2021, more than 209 million people across the world had been infected by COVID-19, with the United States accounting for more than 36 million cases and 618 000 deaths.1 COVID-19 disproportionately affects racial and ethnic minority groups.2 To reduce exposure and mortality rates, it is critical to identify the disparities associated with greater occurrences of COVID-19 among different populations.3
In a meta-analysis of 50 articles,4 it was shown that African American and Asian American patients were at a higher risk of intensive care unit (ICU) admission because of COVID-19 than White patients. A separate meta-analysis examining 45 articles5 indicated that race may be associated with worse COVID-19 outcomes because of the increased occurrence of comorbidities in racial and ethnic minority groups. However, these studies did not examine the role of socioeconomic determinants, which disproportionately affect racial and ethnic minority populations. Another study6 explored underlying factors for COVID-19 outcomes in racial and ethnic minority groups but did not integrate data from external sources, such as county median income. As such, current meta-analyses lack investigations assessing how socioeconomic determinants may be associated with COVID-19 disease severity in minority populations.
Individual cross-sectional and cohort studies have found that COVID-19 infection rates in racial and ethnic minority groups are associated with low socioeconomic status and income.7,8 Specifically, studies have found that there is a positive association between COVID-19 risk and area deprivation index (ADI).9 Past studies have also demonstrated that 11.7% of African Americans individuals are uninsured, compared with 7.5% of White individuals, thus potentially leading to more severe disease outcomes because of lack of access to medical care.10 Geographic variation may also play a role in COVID-19 disease severity, as rural hospitals and communities often lack resources.11 Therefore, it is plausible that these social determinants might be associated with COVID-19 disease severity in racial and ethnic minority populations.
In this study, we examine the associations of race and ethnicity with COVID-19 positivity rates, mortality, hospitalization, and ICU admission in the United States. We then associate these outcomes with various social determinants through adjusted and unadjusted relative risk ratio (RR) and odds ratio (OR) calculations and metaregression analysis. To our knowledge, we are the first to examine social determinants of health in racial disparities of COVID-19 outcomes through a systematic review and meta-analysis, which provides a more accurate understanding than results published in single-site studies.
Database Search and Inclusion Criteria
We conducted a systematic search of studies published from January 1, 2020, to January 6, 2021, in the PubMed, medRxiv, bioRxiv, Embase, and the World Health Organization COVID-19 databases. We used search terms pertaining to COVID-19 and disparities (eMethods 1 in the Supplement) and only included studies that reported data on race and ethnicity as well as the following variables: socioeconomic status, COVID-19 positivity, hospitalization, ICU admission, mortality, and location/geography. All included studies were conducted in the United States.
Two independent reviewers (S.M. and D.J.) screened the titles, abstracts, and full text of each eligible study from the selected databases. Disagreements were resolved through discussion with a third reviewer (Y.L.). We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline for selection of papers in this meta-analysis (eFigure 1 and eMethods 2 in the Supplement). The Joanna Briggs Institute critical appraisal tools were used to assess the quality of evidence from all studies in respect to study design. Studies were not included in our analysis if they scored lower than a 6 of 8 (75%) for cohort studies and 9 of 11 (82%) for cross-sectional studies. The complete search and inclusion strategy can be found in the eMethods 1 and 2 in the Supplement.
Data were extracted from the 68 studies screened with the PRISMA guidelines. We collected details from studies regarding study setting and type and patient demographic characteristics, comorbidities, and outcomes (eMethods 1 in the Supplement), using the same independent reviewer design as during study selection. Following the initial data review, socioeconomic variables quantifying disparities in health, income, and geography were extracted from external sources using zip code and congressional district location (eMethods 1 in the Supplement).12-15 External measures of socioeconomic disparities were not extracted for studies that occurred at a statewide level or that included data from patients across the United States, as the specific tools we used to determine these values were limited by units of analysis at the county, congressional district, and/or geographic address level.
COVID-19 has been strongly associated with lower socioeconomic status in racial/ethnic minorities.16 Accordingly, ADI was used as a quantitative measure of socioeconomic disadvantage, and it accounts for several factors, such as income, education, employment, and housing quality. The Urban Core Opportunity Index (UOI) measures the urbanicity of geographic location, through the characterization of factors such as the amount of renters and households without vehicles.15
We also examined the association of clinical care quality with COVID-19 positivity, mortality, ICU admission, and hospitalization through metaregression analysis. Specifically, we investigated the following measures of clinical care quality: preventable hospital stays, ratio of the population to primary care physicians, and percentage of uninsured individuals. A higher rate of preventable hospital stays represents a lower quality of available medical care, and a higher ratio of the population to physicians refers to a larger population with access to only 1 primary care physician.14
All data analysis was conducted using R Studio version 4.1.1 (R Project for Statistical Computing). Analyses were conducted separately for each racial and ethnic group in the following cohorts: COVID-19 positivity, ICU admission, hospitalization, and mortality. Studies with missing data for a particular cohort or variable were excluded from the respective analysis. The following analyses were conducted to investigate the association of race and ethnicity with COVID-19 outcomes. Combined prevalence refers to the incidence of COVID-19 outcomes in a certain population per 1000 patients. Metaregression analysis was conducted to assess associations between study effect size and socioeconomic variables extracted by study location. Relative risk ratios (RRs) and odds ratios (ORs) were also used to assess the associations of race and ethnicity with COVID-19 outcomes, with White individuals as the reference group. Both RR and OR values were adjusted for several key confounders using a linear mixed-effect model (eMethods 3 in the Supplement). Statistical significance was set at P < .05, and all tests were 2-tailed. The Egger test was used to assess publication bias, with P < .05 as the level of statistical significance (eFigures 2-4 in the Supplement). Information for all the studies is reported in detail in eTables 1 and 2 in the Supplement.
A total of 4 318 929 patients from 68 studies17-84 were included in this meta-analysis (Table). Overall, 370 933 patients (8.6%) were African American, 9082 (0.2%) were American Indian or Alaska Native, 101 793 (2.4%) were Asian American, 851 392 identified as Hispanic/Latino (19.7%), 7417 (0.2%) were Pacific Islander, 1 037 996 (24.0%) were White, and 269 040 (6.2%) identified as multiracial or of other racial or ethnic group. The studies were separated into cohort and cross-sectional studies for data analysis. All unadjusted and adjusted RR and OR values are reported in Figure 1 and Figure 2 and eTables 3 and 4 in the Supplement.
COVID-19 Positivity Rates
In age- and sex-adjusted analyses, we found that African American and Hispanic individuals were significantly more likely to test positive for COVID-19 than White individuals (African American: RR, 3.54; 95% CI, 1.38-9.07; P = .008; Hispanic: RR, 4.68; 95% CI, 1.28-17.20, P = .02) (Figure 1). There was a lack of data to calculate age- and sex-adjusted RR and OR values for Asian American individuals. Following adjustment for ADI, African American and Hispanic individuals were almost 2 times as likely to test positive for COVID-19 as White individuals (African American: RR, 2.01; 95% CI, 1.04-3.88; P = .04; Hispanic: RR, 2.09; 95% CI, 1.13-3.88; P = .02), followed by Asian American individuals (RR, 1.12; 95% CI, 1.04-1.21; P = .003) (Figure 1). After adjustment for clinical care quality, we found that African American individuals were still the most likely to test positive for COVID-19 (RR, 1.79; 95% CI, 1.11-3.17; P = .03), followed by Asian American individuals (RR, 1.16; 95% CI, 1.03-1.31; P = .02) (Figure 1). Hispanic individuals did not exhibit significant results following adjustment for clinical care quality. Interestingly, adjustment for the UOI demonstrated that Asian American individuals face the highest risk of COVID-19 positivity (RR, 1.13; 95% CI, 1.07-1.19, P < .001) (eTable 3 in the Supplement). We did not observe significant results in African American and Hispanic individuals following adjustment for UOI. Combined prevalence values demonstrated similar trends, with African American individuals having the highest prevalence of COVID-19 positivity (eFigure 5 in the Supplement). In summary, with some exceptions, adjusting for ADI and clinical care quality significantly decreased the risk of COVID-19 infection in African American and Hispanic individuals when compared with White individuals. However, the risk still remained high in these populations following adjustment.
COVID-19 disease severity was assessed through ICU admission and hospitalization rates among various racial and ethnic groups (eFigure 6 in the Supplement). Following adjustment for sex, Asian American individuals had a significant RR of 1.93 (95% CI, 1.60-2.34; P < .001) compared with White individuals (Figure 1).
Mortality Rates in Cohort and Cross-sectional Studies
The combined prevalence of COVID-19 mortality rates in cohort studies was highest among White individuals (161.12 per 1000 patients), followed by African American individuals (143.99 per 1000 patients), Hispanic/Latino individuals (130.51 per 1000 patients), and Asian American individuals (42.99 per 1000 patients) (eTable 5 in the Supplement). In cross-sectional studies, the combined prevalence of mortality rates were highest among African American individuals (277.15 per 1000 patients), followed by Hispanic individuals (213.34 per 1000 patients), White individuals (173.38 per 1000 patients), and Asian individuals (80.4 per 1000 patients) (eTable 5 and eFigure 7 in the Supplement).
In cross-sectional studies, the ADI-adjusted RR for mortality was 0.44 (95% CI, 0.31-0.61; P < .001) for Hispanic individuals, and the county median income–adjusted RRs for mortality were 0.43 (95% CI, 0.41-0.46; P < .001) for Hispanic individuals and 0.44 (95% CI, 0.36-0.54; P = .001) for Asian American individuals.
ADI and Racial Disparities in COVID-19 Mortality
We further investigated the association of ADI with COVID-19 positivity and disease severity by race and ethnicity through metaregression analysis. A higher ADI corresponds to worse socioeconomic status. Accordingly, we found that an increase in ADI was positively associated with the mortality rates of Asian American and Hispanic individuals in cross-sectional studies (P < .001) (Figure 3). Interestingly, an increase in ADI was negatively associated with mortality rates of Hispanic individuals in cohort studies (P = .03) (Figure 3).
Metaregression With County Median Income
We conducted metaregression analysis to assess the association of county median income with COVID-19 outcomes by race and ethnicity. Although ADI is a more comprehensive measure of socioeconomic deprivation, we also analyzed county median income because it provided more significant results for RR/OR adjustment in comparison with ADI. Therefore, we determined that we should further examine any associations with income, as it may have been more strongly associated with COVID-19 outcomes than other socioeconomic measures included in ADI. In cohort studies, we found that county median income was negatively associated with mortality rates in Asian American populations (P < .001). In cross-sectional studies, higher county median income was associated with lower mortality rates in Hispanic and African American individuals (P < .001). County median income was also negatively associated with the proportion of White individuals admitted to the ICU (P = .02) (Figure 4; eFigure 8 in the Supplement).
Through further metaregression analysis, we determined that Hispanic individuals had a positive association of increasing income and positivity rates (P = .03). However, African American individuals displayed a negative association between income and positivity rates (P = .02).
We additionally conducted Spearman correlations to assess the degree of association between these studied determinants. We observed a strong, positive correlation between county median income and area deprivation index (R = 0.61; P < .001), as county median income was among the measures included in developing the ADI (eFigure 9 in the Supplement). We found there was a lesser degree of association between county median income and measures of clinical care quality (eFigure 9 in the Supplement).
Metaregression With Clinical Care Variables
In cohort studies, we found that an increase in number of preventable hospital stays (P = .04) and the population served by 1 primary care physician (P = .009) were associated with a decrease in positivity among Asian American individuals (eFigure 10 in the Supplement). Conversely, the population served by 1 primary care physician was positively associated with COVID-19 positivity among Hispanic individuals (P < .001). In cross-sectional studies, we found that the ratio of the population served to primary care physicians was positively correlated with mortality among White individuals (P < .001). The percentage of uninsured individuals was positively associated with positivity among African American (P < .001) and White (P = .01) individuals in cohort and cross-sectional studies.
Risk of Bias Across Studies
We found that cohort studies detailing the proportion of Asian American and Hispanic individuals who tested positive for COVID-19, cohort studies detailing the proportion of Asian American individuals admitted to the ICU, cross-sectional studies detailing the proportion of Asian American individuals who died, and cohort studies detailing the proportion of African American individuals who died exhibited publication bias. To evaluate the association of study heterogeneity with summary proportions, we conducted leave-one-out sensitivity analysis to measure the effects of outliers (eTable 6 and eFigures 11-13 in the Supplement). We found that summary proportions were not significantly altered by the removal of these outliers (eFigures 14 and 15 in the Supplement). However, we observed that following the removal of the outlier in the COVID-19 mortality group (ie, cohort studies), African American individuals had the highest rate of mortality followed by Asian American individuals. Prior to removal of the outlier, we found that mortality rates were highest among White individuals. We additionally observed high heterogeneity statistics in our results, indicating that there may be variability in the studies included.
In our meta-analysis, we found that COVID-19 positivity and ICU admission rates were higher in African American, Hispanic, and Asian American individuals compared with White individuals, with some exceptions. Our results are consistent with previous findings that suggest that racial and ethnic minority groups face a higher risk of ICU admission and COVID-19 positivity than White populations.65,85-89
However, current meta-analyses do not provide associations with socioeconomic variables, which are highly implicated in COVID-19 outcomes. Therefore, in this study, we aimed to investigate both racial and ethnic disparities in COVID-19 outcomes as well as their associations with socioeconomic variables.
Following adjustment for ADI and clinical care quality, we found that risk of COVID-19 positivity in African-American and Hispanic individuals substantially decreased. However, the risk for COVID-19 positivity following adjustment remained higher in these minoritized populations when compared with White individuals. As such, this occurrence may be because of the overrepresentation of members of racial and ethnic minority groups in essential jobs, which increase exposure to COVID-19. Furthermore, comorbidities, such as hypertension or obesity, are prevalent among minority populations, thus contributing to worsened disease outcomes.8,90,91 To our knowledge, we are the first to adjust RRs and ORs of race-associated COVID-19 outcomes using health care quality and access.
We further examined the association of socioeconomic determinants with COVID-19 positivity rates, mortality rates, hospitalization, and ICU admission in racial and ethnic minority groups through metaregression analysis. Increased deprivation was found to be associated with increased mortality in Asian American individuals. Paradoxically, an increase in county median income was associated with increased mortality rates in Asian American individuals. This result suggests that factors other than income that contribute to ADI, such as education, housing equality, and employment, could affect Asian American populations. One hypothesis is that a large number of Asian American individuals work in health care settings, which can lead to increased mortality rates that do not reflect the general population of the surrounding community.92
An increase in deprivation was also found to be associated with decreased mortality rates in Hispanic individuals in cohort studies, although the opposite result was seen in cross-sectional studies. This inconsistency suggests that further research is needed to establish conclusively the association between mortality rates and deprivation in Hispanics.
We additionally assessed associations between measures of clinical care quality and COVID-19 outcomes. Curiously, we found that an increase in preventable hospital stays and the population served by 1 primary physician were associated with a decrease in the percentage of Asian American individuals who tested positive for COVID-19, suggesting again that other variables may be affecting COVID-19 positivity rates in this population.
Conversely, we observed a positive association between lack of primary care physician access (ie, increased ratio of population to physician) and COVID-19 positivity among Hispanic individuals. Past studies have demonstrated that Hispanic individuals are less likely to delay care if the primary care physician to patient ratio is improved.93
An increase in the number of uninsured individuals was also positively associated with COVID-19 positivity among African American individuals. African American individuals are less likely to have health insurance coverage compared with White individuals.94 Members of racial and ethnic minority groups who are uninsured may also not have access to COVID-19 tests.10
Collectively, our findings demonstrate that racial and ethnic minority groups have faced higher risk of COVID-19 positivity and ICU admission. Public health policies should address socioeconomic and racial disparities to reduce exposure to and fatality from COVID-19 in underrepresented populations. Increasing equitable access to health care and improving resources for underserved populations may reduce exposure to COVID-19 in racial/ethnic minorities.
Our study has several limitations. First, we found high heterogeneity statistics, indicating that there may be variation in the effect sizes of the studies. Second, a number of publications that were included had incomplete or missing data on mortality, positivity, ICU admission, and hospitalization rates. Moreover, there were limited data on several racial and ethnic groups. There was also a lack of information on comorbidities and socioeconomic status variables (ADI, UOI, clinical care quality, income), which limited our ability to adjust for all variables in the multivariable models, although we were able to adjust for some variables individually in separate models (eTables 3 and 4 in the Supplement). Imputation methods were considered but not pursued as it would be difficult to accurately impute measures from patient studies in distinct health systems.
Additionally, several study cohorts exhibited publication bias. As publication bias reduces the accuracy of results, the validity of results in these particular study cohorts may be limited.
In this study, African American, Hispanic, and Asian American individuals were at considerably higher risk of COVID-19 positivity and ICU admission compared with White individuals. Adjustment for social determinants of health and socioeconomic factors decreased risks of COVID-19 positivity in racial and ethnic minority groups; however, several factors were not accounted for by these variables. We also observed that decreased access to clinical care was positively associated with COVID-19 positivity in Hispanic and African American individuals. In conclusion, we found that racial and ethnic disparities in COVID-19 outcomes could be accounted for by socioeconomic determinants in some populations, such as African American, Hispanic, and Asian American individuals.
Accepted for Publication: September 12, 2021.
Published: November 11, 2021. doi:10.1001/jamanetworkopen.2021.34147
Correction: This article was corrected on December 21, 2021, to fix errors in Figures 1 and 2, and on February 24, 2022, to remove the interpretation of mortality risk estimates from unadjusted regression models.
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Magesh S et al. JAMA Network Open.
Corresponding Author: Weg M. Ongkeko, MD, PhD, Division of Otolaryngology–Head and Neck Surgery, Department of Surgery, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093 (rongkeko@health.ucsd.edu).
Author Contributions: Dr Ongkeko had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Ms Magesh, Mr John, and Mr W. Li contributed equally and are co–first authors.
Concept and design: Magesh, John, W. Li, Mattingly-app, Ongkeko.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Magesh, John, Mattingly-app, Ongkeko.
Critical revision of the manuscript for important intellectual content: Magesh, John, W. Li, Y. Li, Jain, Chang, Ongkeko.
Statistical analysis: Magesh, John, W. Li, Y. Li, Mattingly-app.
Obtained funding: Chang, Ongkeko.
Administrative, technical, or material support: W. Li, Y. Li, Jain, Ongkeko.
Supervision: W. Li, Ongkeko.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was supported by grant R00RG2369 from the University of California, Office of the President/Tobacco-Related Disease Research Program Emergency COVID-19 Research Seed Funding to Dr Ongkeko.
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
3.Shah
SJ, Barish
PN, Prasad
PA,
et al; CZB CLIAhub Consortium. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a retrospective cohort study of patients with and without COVID-19.
EClinicalMedicine. 2020;27(27):100518. doi:
10.1016/j.eclinm.2020.100518PubMedGoogle Scholar 6.Mackey
K, Ayers
CK, Kondo
KK,
et al. Racial and ethnic disparities in COVID-19–related infections, hospitalizations, and deaths : a systematic review.
Ann Intern Med. 2021;174(3):362-373. doi:
10.7326/M20-6306PubMedGoogle ScholarCrossref 7.Samuel
LJ, Gaskin
DJ, Trujillo
AJ, Szanton
SL, Samuel
A, Slade
E. Race, ethnicity, poverty and the social determinants of the coronavirus divide: U.S. county-level disparities and risk factors.
BMC Public Health. 2021;21(1):1250. doi:
10.1186/s12889-021-11205-wPubMedGoogle ScholarCrossref 10.Vasquez Reyes
M. The disproportional impact of COVID-19 on African Americans.
Health Hum Rights. 2020;22(2):299-307.
PubMedGoogle Scholar 16.Yaya
S, Yeboah
H, Charles
CH, Otu
A, Labonte
R. Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest.
BMJ Glob Health. 2020;5(6):e002913. doi:
10.1136/bmjgh-2020-002913PubMedGoogle Scholar 18.Khan
A, Chatterjee
A, Singh
S. Comorbidities and disparities in outcomes of COVID-19 among Black and White patients. medRxiv. Preprint published May 15, 2020. doi:
10.1101/2020.05.10.20090167 19.Pan
AP, Khan
O, Meeks
JR,
et al. Disparities in COVID-19 hospitalizations and mortality among Black and Hispanic patients: cross-sectional analysis from the greater Houston metropolitan area.
BMC Public Health. 2021;21(1):1330. doi:
10.1186/s12889-021-11431-2PubMedGoogle ScholarCrossref 20.Feehan
AK, Fort
D, Garcia-Diaz
J,
et al. Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9-15, 2020. medRxiv. Preprint published June 24, 2020. doi:
10.1101/2020.06.23.20138321 23.Bhargava
A, Sharma
M, Riederer
K, Fukushima
EA, Szpunar
SM, Saravolatz
L. Risk factors for in-hospital mortality from COVID-19 infection among Black Patients—an urban center experience.
Clin Infect Dis. 2020;ciaa1468. doi:
10.1093/cid/ciaa1468PubMedGoogle Scholar 24.Baidal
JW, Wang
AY, Zumwalt
K,
et al. Social determinants of health and COVID-19 among patients in New York City.
Res Sq. Preprint published September 15, 2020. doi:
10.21203/rs.3.rs-70959/v1Google Scholar 27.Renelus
BD, Khoury
NC, Chandrasekaran
K,
et al. Racial disparities in COVID-19 hospitalization and in-hospital mortality at the height of the New York City pandemic.
J Racial Ethn Health Disparities. 2020.
PubMedGoogle Scholar 29.Dixon
BE, Wools-Kaloustian
K, Fadel
WF,
et al. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: results from a statewide epidemiological study.
medRxiv. Preprint updated October 22, 2020. doi:
10.1101/2020.10.11.20210922Google Scholar 31.Bui
DP, McCaffrey
K, Friedrichs
M,
et al. Racial and ethnic disparities among COVID-19 cases in workplace outbreaks by industry sector—Utah, March 6-June 5, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(33):1133-1138. doi:
10.15585/mmwr.mm6933e3PubMedGoogle ScholarCrossref 33.McCarthy
CP, Murphy
S, Jones-O’Connor
M,
et al. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system.
EClinicalMedicine. 2020;26(26):100504. doi:
10.1016/j.eclinm.2020.100504PubMedGoogle Scholar 36.Marmarchi
F, Liu
M, Rangaraju
S,
et al; Emory COVID-19 Quality and Clinical Research Collaborative (QCRC). Clinical outcomes of critically iii patients with COVID-19 by race.
J Racial Ethn Health Disparities. Published online January 19, 2021. doi:
10.1007/s40615-021-00966-0PubMedGoogle Scholar 37.Vahidy
FS, Nicolas
JC, Meeks
JR,
et al. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
BMJ Open. 2020;10(8):e039849. doi:
10.1136/bmjopen-2020-039849PubMedGoogle Scholar 38.Rodriguez
F, Solomon
N, de Lemos
JA,
et al. Racial and ethnic differences in presentation and outcomes for patients hospitalized with COVID-19: findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry.
Circulation. 2021;143(24):2332-2342. doi:
10.1161/CIRCULATIONAHA.120.052278PubMedGoogle ScholarCrossref 39.Cromer
SJ, Lakhani
CM, Wexler
DJ, Burnett-Bowie
SA, Udler
M, Patel
CJ. Geospatial analysis of individual and community-level socioeconomic factors impacting SARS-CoV-2 prevalence and outcomes.
medRxiv. Preprint published September 30, 2020. doi:
10.1101/2020.09.30.20201830Google Scholar 40.Abrams
MP, Wan
EY, Waase
MP,
et al. Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City cohort.
J Cardiovasc Electrophysiol. 2020;31(12):3086-3096. doi:
10.1111/jce.14772PubMedGoogle ScholarCrossref 43.Chen
H, Varantharajah
Y, de Ramirez
SS,
et al. A retrospective longitudinal study of COVID-19 as seen by a large urban hospital in Chicago. Preprint published November 30, 2020. doi:
10.1101/2020.11.29.20240606 44.Hsu
HE, Ashe
EM, Silverstein
M,
et al. Race/ethnicity, underlying medical conditions, homelessness, and hospitalization status of adult patients with COVID-19 at an urban safety-net medical center—Boston, Massachusetts, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(27):864-869. doi:
10.15585/mmwr.mm6927a3PubMedGoogle ScholarCrossref 45.Goldfarb
IT, Clapp
MA, Soffer
MD,
et al. Prevalence and severity of coronavirus disease 2019 (COVID-19) illness in symptomatic pregnant and postpartum women stratified by Hispanic ethnicity.
Obstet Gynecol. 2020;136(2):300-302. doi:
10.1097/AOG.0000000000004005PubMedGoogle ScholarCrossref 46.Bassett
IV, Triant
VA, Bunda
BA,
et al. Massachusetts General Hospital COVID-19 registry reveals two distinct populations of hospitalized patients by race and ethnicity.
PLoS One. 2020;15(12):e0244270. doi:
10.1371/journal.pone.0244270PubMedGoogle Scholar 50.Joseph
NT, Stanhope
KK, Badell
ML, Horton
JP, Boulet
SL, Jamieson
DJ. Sociodemographic predictors of SARS-CoV-2 infection in obstetric patients, Georgia, USA.
Emerg Infect Dis. 2020;26(11):2787-2789. doi:
10.3201/eid2611.203091PubMedGoogle ScholarCrossref 52.Tenforde
MW, Billig Rose
E, Lindsell
CJ,
et al; CDC COVID-19 Response Team. Characteristics of adult outpatients and inpatients with COVID-19—11 academic medical centers, United States, March-May 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(26):841-846. doi:
10.15585/mmwr.mm6926e3PubMedGoogle ScholarCrossref 54.McPadden
J, Warner
F, Young
HP,
et al. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 Infection.
medRxiv. Preprint revised November 8, 2020. doi:
10.1101/2020.07.19.20157305Google Scholar 55.Adams
ML, Grandpre
J, Katz
DL. Updated estimates of comorbidities associated with risk for COVID-19 complications based on US data.
medRxiv. Preprint published May 6, 2020. doi:
10.1101/2020.05.02.20088781Google Scholar 58.Ingraham
NE, Purcell LN, Karam BS,
et al. Racial/ethnic disparities in hospital admissions from COVID-19 and determining the impact of neighborhood deprivation and primary language.
medRxiv. Preprint revised September 22, 2020. doi:
10.1101/2020.09.02.20185983Google Scholar 61.Menachemi
N, Yiannoutsos
CT, Dixon
BE,
et al. Population point prevalence of SARS-CoV-2 infection based on a statewide random sample—Indiana, April 25-29, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(29):960-964. doi:
10.15585/mmwr.mm6929e1PubMedGoogle ScholarCrossref 62.Mendy
A, Apewokin
S, Wells
AA, Morrow
AL. Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients.
medRxiv. Preprint published June 27, 2020. doi:
10.1101/2020.06.25.20137323Google Scholar 63.Pathak
I, Choi
Y, Jiao
D, Yeung
D, Liu
L. Racial-ethnic disparities in case fatality ratio narrowed after age standardization: a call for race-ethnicity-specific age distributions in state COVID-19 data.
medRxiv. Preprint published October 4, 2020. doi:
10.1101/2020.10.01.20205377Google Scholar 66.Reichberg
SB, Mitra
PP, Haghamad
A,
et al; Northwell COVID-19 Research Consortium. Rapid emergence of SARS-CoV-2 in the greater New York metropolitan area: geolocation, demographics, positivity rates, and hospitalization for 46 793 persons tested by Northwell Health.
Clin Infect Dis. 2020;71(12):3204-3213. doi:
10.1093/cid/ciaa922PubMedGoogle ScholarCrossref 69.Waltenburg
MA, Rose
CE, Victoroff
T,
et al; CDC COVID-; Emergency Response Team. Coronavirus disease among workers in food processing, food manufacturing, and agriculture workplaces.
Emerg Infect Dis. 2021;27(1). doi:
10.3201/eid2701.203821PubMedGoogle Scholar 70.Gottlieb
M, Sansom
S, Frankenberger
C, Ward
E, Hota
B. Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, Illinois.
Acad Emerg Med. 2020;27(10):963-973. doi:
10.1111/acem.14104PubMedGoogle ScholarCrossref 71.Misa
NY, Perez
B, Basham
K,
et al. Racial/ethnic disparities in COVID-19 disease burden & mortality among emergency department patients in a safety net health system.
Am J Emerg Med. 2021;45:451-457.
PubMedGoogle ScholarCrossref 75.Gayam
V, Chobufo
MD, Merghani
MA, Lamichhane
S, Garlapati
PR, Adler
MK. Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York.
J Med Virol. 2021;93(2):812-819. doi:
10.1002/jmv.26306PubMedGoogle ScholarCrossref 78.Ahmed
SM, Shah
RU, Bale
M,
et al. Comprehensive testing highlights racial, ethnic, and age disparities in the COVID-19 outbreak: epidemiological and clinical characteristic of cases in Utah.
medRxiv. Preprint published May 9, 2020. doi:
10.1101/2020.05.05.20092031Google Scholar 79.Silver
V, Chapple
AG, Feibus
AH,
et al. Clinical characteristics and outcomes based on race of hospitalized patients with COVID-19 in a New Orleans cohort.
Open Forum Infect Dis. 2020;7(9):a339. doi:
10.1093/ofid/ofaa339PubMedGoogle ScholarCrossref 80.Tartof
SY, Qian
L, Hong
V,
et al. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization.
Ann Intern Med. 2020;173(10):773-781. doi:
10.7326/M20-3742PubMedGoogle ScholarCrossref 81.Self
WH, Semler
MW, Leither
LM,
et al; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial.
JAMA. 2020;324(21):2165-2176. doi:
10.1001/jama.2020.22240PubMedGoogle ScholarCrossref 82.Xiong
D, Zhang
L, Watson
GL,
et al. Pseudo-likelihood based logistic regression for estimating COVID-19 infection and case fatality rates by gender, race, and age in California.
Epidemics. 2020;33:100418. doi:
10.1016/j.epidem.2020.100418PubMedGoogle Scholar 83.Mukherjee
V, Toth
AT, Fenianos
M,
et al. Clinical outcomes in critically ill coronavirus disease 2019 patients: a unique New York City public hospital experience.
Crit Care Explor. 2020;2(8):e0188. doi:
10.1097/CCE.0000000000000188PubMedGoogle Scholar 88.Bhattacharyya
A, Seth
A, Srivast
N, Imeokparia
M, Rei
S. Coronavirus (COVID-19): a systematic review and meta-analysis to evaluate the significance of demographics and comorbidities.
Res Sq. Preprint published January 18, 2021. doi:
10.21203/rs.3.rs-144684/v1Google Scholar 89.Rentsch
CT, Kidwai-Khan
F, Tate
JP,
et al. Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: a nationwide cohort study.
PLoS Med. 2020;17(9):e1003379. doi:
10.1371/journal.pmed.1003379PubMedGoogle Scholar 93.Oh
H, Trinh
MP, Vang
C, Becerra
D. Addressing barriers to primary care access for Latinos in the US: an agent-based model.
J Soc Social Work and Res. 2020;11(2):165-184. doi:
10.1086/708616Google ScholarCrossref